Lymphoma, Leukemia, and Myeloma Congress

The Lymphoma, Leukemia & Myeloma Congress Portfolio, also known as the LL&M Portfolio, includes three hematology oncology education events: LL&M Congress, LL&M Great Debates, and LL&M Winter Symposium. Across the portfolio, these CME-accredited conferences support clinicians who manage blood cancers, including lymphoma, leukemia, chronic lymphocytic leukemia, and multiple myeloma.

LL&M events provide focused hematology education for clinicians looking for lymphoma, leukemia, CLL, and multiple myeloma programming within a broader blood cancer conference portfolio.

All three events cover the full spectrum of hematologic malignancies:

- Lymphoma (DLBCL, follicular, mantle cell, Hodgkin)
- Leukemia (AML, ALL, CML)
- Chronic lymphocytic leukemia (CLL)
- Multiple myeloma

Clinical topics include CAR-T cell therapy, bispecific antibodies, BTK inhibitors, BCL-2 inhibitors, MRD-guided treatment decisions, and treatment sequencing in relapsed and refractory disease.

LL&M meetings are designed for hematologists, medical oncologists, NPs and PAs, nurses, fellows, residents, and oncology pharmacists involved in the care of patients with hematologic malignancies. Depending on the event, attendees may earn CME or CE credit while engaging with case-based education across lymphoma, leukemia, chronic lymphocytic leukemia, and multiple myeloma.

LL&M Congress is the flagship annual hematology conference. Held each fall in New York City, the four-day program offers 25+ CME credits and case-based education across lymphoma, leukemia, chronic lymphocytic leukemia, and multiple myeloma.

LL&M Great Debates is the debate-format hematology meeting. Held mid-year in two cities, the program is built for clinical questions where the evidence points in more than one direction.

LL&M Winter Symposium is the first major hematology meeting of the year. Held each February in Miami, the three-day program focuses on translating recent global hematology research into clinical practice.